Where can I buy shares of NSPR?
Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
When did inspiremd shares reverse split?
InspireMD shares reverse split before market open on Tuesday, April 27th 2021. The 1-15 reverse split was announced on Wednesday, April 14th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 26th 2021.
What are analysts' price targets for inspiremd's stock?
1 brokerages have issued 12 month price targets for InspireMD's stock. Their forecasts range from $10.50 to $10.50. On average, they anticipate InspireMD's stock price to reach $10.50 in the next year. This suggests a possible upside of 132.8% from the stock's current price.
Will Nspr go up?
InspireMD Inc (NASDAQ:NSPR) The 1 analysts offering 12-month price forecasts for InspireMD Inc have a median target of 5.25, with a high estimate of 5.25 and a low estimate of 5.25. The median estimate represents a +156.10% increase from the last price of 2.05.
What does InspireMD Inc do?
InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) delivering neurovascular protection and stroke prevention.
Did Nspr reverse split?
InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR. WSB) recently announced a 1-for-15 reverse split of its common stock, effective as of yesterday.
What does Nspr stand for?
NSPRAcronymDefinitionNSPRNational Society for Park Resources (National Recreation and Park Association)NSPRNational Society of Pershing Rifles (US drill team organization)NSPRNational Strategy of Poverty Reduction (various nations)NSPRNational Standards of Puerto Rico (metrology)3 more rows
What happens to warrants when a stock splits?
The number of shares of common stock issued subject to stock options, warrants, or convertible securities will automatically be proportionately decreased by the split ratio and the exercise price or conversion ratio will automatically be proportionately increased by the same split ratio.
When did NSPR's 4th split take place?
For example, a 150 share position pre-split, became a 6 share position following the split. NSPR's 4th split took place on April 01, 2019. This was a 1 for 50 reverse split, meaning for each 50 shares of NSPR owned pre-split, the shareholder now owned 1 share.
When is the 5th NSPR split?
NSPR's 5th split took place on April 27, 2021. This was a 1 for 15 reverse split, meaning for each 15 shares of NSPR owned pre-split, the shareholder now owned 1 share. For example, a 0.12 share position pre-split, became a 0.008 share position following the split.
How many splits does InspireMD have?
InspireMD (NSPR) has 5 splits in our NSPR split history database. The first split for NSPR took place on August 18, 1998. This was a 3 for 2 split, meaning for each 2 shares of NSPR owned pre-split, the shareholder now owned 3 shares.
What happens when a company splits its stock?
When a company such as InspireMD splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers.
Why are $5 and $10 pricepoints important?
This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility.
Why does InspireMD reverse share split?
When a company such as InspireMD conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like.
What happens when a company reverses its split?
So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
What is NSPRW in 2021?
(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Caro tid Artery Disease (CAD), today announced the Company’s warrants, NSPR.WS and NSPR.WSB, currently traded on the NYSE: American, have been approved for listing on The Nasdaq Capital Market (“Nasdaq”). Trading is expected to begin on June 8, 2021, under the symbols NSPRW and NSPRZ on the Nasdaq. About InspireMD, Inc. InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes. Forward-looking Statements This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) product malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (ix) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (x) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (xi) our reliance on single suppliers for certain product components, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xiii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. Investor Contacts: Craig ShoreChief Financial OfficerInspireMD, [email protected] CORE [email protected]
How much was revenue in the first quarter of 2021?
Financial Results for the First Quarter ended March 31, 2021 For the three months ended March 31, 2021, revenue decreased by $28,000, or 2.7%, to $1,006,000, from $1,034,000 during the three months ended March 31, 2020.
How much was the increase in write offs for 2021?
This decrease in gross profit resulted from an increase in write-offs of $156,000, which were driven mainly by a component supply issue during the three months ended March 31, 2021 and an increase of $33,000 in miscellaneous expenses during the three months ended March 31, 2021.
How much is Cguard revenue in 2021?
CGuard revenue remained essentially unchanged at $969,000 during the three months ended March 31, 2021 as compared to $971,000 during the three months ended March 31, 2020, in spite of the continued postponement of many elective procedures as a result of the residual COVID directed resources.
How much was the financial income increase in 2021?
For the three months ended March 31, 2021, financial income increased by 65.1%, or $28,000, to $71,000, from $43,000 during the three months ended March 31, 2020. The increase in financial income primarily resulted from changes in exchange rates.
When is Inspire MD's earnings call 2021?
(AMEX:NSPR) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 11, 2021 at 8:30 AM Eastern Time.
What is the gross margin for 2021?
Gross margin (gross profits as a percentage of revenue) decreased to 10.5% during the three months ended March 31, 2021 from 28.5% during the three months ended March 31, 2020, driven by the factors mentioned above.
When will InspireMD reverse split?
Shares of InspireMD reverse split on Tuesday, April 27th 2021. The 1-15 reverse split was announced on Wednesday, April 14th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 26th 2021. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 7 shares after ...
Is Marketbeat better than InspireMD?
What stocks does MarketBeat like better than InspireMD? Wall Street analysts have given InspireMD a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains.
InspireMD (NSPR)
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Style Scorecard
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
Chart for NSPR
InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard (TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions.